Date: 17 Dec 2008
Prevalence and Trends of Receipt of Cancer Screenings Among US Women with Diagnosed Diabetes
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Diabetes increases the risk of breast and colorectal cancers and has an undetermined relationship to cervical cancer. Improved screenings for these cancers are effective in reducing cancer mortality.
To examine the prevalence of receiving recommended screenings for these cancers and to assess the trends in the screening rates over time among US women with diagnosed diabetes in comparison with women without diabetes.
A total of 63,650 to 182,168 adult women participated in the 1996−2006 (biennially) Behavioral Risk Factor Surveillance System.
The prevalence of receiving cancer screenings was age-standardized to the 2000 US population. The adjusted prevalence and adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were estimated using logistic regression analyses. The linear trends in the screening rates were tested using orthogonal polynomial contrasts.
In 2006, women with diabetes had a lower adjusted prevalence (74% versus 79%, P < 0.05) and the AOR (0.73, 95% CI: 0.66−0.81) for receiving cervical cancer screenings, but had a higher adjusted prevalence (63% versus 60%, P < 0.05) and the AOR (1.14, 95% CI: 1.04−1.24) for receiving colorectal cancer screenings compared to those without. In both women with diabetes and those without, the screening rate for colorectal cancer increased linearly during 2002−2006, whereas the screening rates for breast and cervical cancers changed little during 1996−2006.
Women with diabetes were equally likely to be screened for breast cancer, less likely to be screened for cervical cancer, but more likely to be screened for colorectal cancer compared to those without. Overall, the screening rates in both groups remain below the recommended levels.
American Cancer Society. Cancer Statistics 2007. Available at URL:http://www.cancer.org/downloads/STT/Cancer_Statistics_Combined_2007.ppt#256,1,Cancer Statistics. Accessed Nov. 12, 2008.
U.S. Department of Health and Human Services. The guide to clinical preventive services, 2007: Recommendations of the U.S. Preventive Services Task Force. Available at URL: http://www.ahrq.gov/clinic/pocketgd07/pocketgd07.pdf. Accessed Nov. 12, 2008.
Morita T, Tabata S, Mineshita M, Mizoue T, Moore MA, Kono S. The metabolic syndrome is associated with increased risk of colorectal adenoma development: the Self-Defense Forces health study. Asian Pac J Cancer Prev. 2005;6:485–9.PubMed
Centers for Disease Control and Prevention. Diabetes Data & Trends. Available at URL: http://www.cdc.gov/diabetes/statistics/prev/national/figbysex.htm. Accessed Nov. 12, 2008.
Ahluwalia IB, Bolen J, Garvin B. Health insurance coverage and use of selected preventive services by working-age women, BRFSS, 2006. J Womens Health. 2007;16:935–40.CrossRef
Nelson DE, Holtzman D, Bolen J, Stanwyck CA, Mack KA. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soc Prev Med. 2001;46(suppl 1):S3-S42.
U.S. Department of Health and Human Services. Healthy People 2010. Available at URL: http://www.healthypeople.gov/Search/objectives.htm. Accessed Nov. 12, 2008.
- Prevalence and Trends of Receipt of Cancer Screenings Among US Women with Diagnosed Diabetes
Journal of General Internal Medicine
Volume 24, Issue 2 , pp 270-275
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- diabetes mellitus
- Papanicolaou test
- fecal occult blood test
- Industry Sectors
- Author Affiliations
- 1. Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA
- 2. Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA